NVAX

SEC source: 0001593968-24-000863 · primary_01.xml · derivative · entry 4

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,420

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

SEC source: 0001593968-24-000863 · primary_01.xml · derivative · entry 3

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Common Stock · 15,630 shares

Expires 2034-06-12

SEC source: 0001593968-24-000863 · primary_01.xml · derivative · entry 2

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,670 shares

Expires 2033-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000863 · primary_01.xml · nonDerivative · entry 1

DOUGLAS RICHARD · CIK 0001021015 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000862 · primary_01.xml · derivative · entry 4

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,420

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

SEC source: 0001593968-24-000862 · primary_01.xml · derivative · entry 3

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Common Stock · 15,630 shares

Expires 2034-06-12

SEC source: 0001593968-24-000862 · primary_01.xml · derivative · entry 2

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,670 shares

Expires 2033-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000862 · primary_01.xml · nonDerivative · entry 1

King Rachel K. · CIK 0001589712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,920

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000861 · primary_01.xml · derivative · entry 4

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,420

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

SEC source: 0001593968-24-000861 · primary_01.xml · derivative · entry 3

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Common Stock · 15,630 shares

Expires 2034-06-12

SEC source: 0001593968-24-000861 · primary_01.xml · derivative · entry 2

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,670 shares

Expires 2033-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000861 · primary_01.xml · nonDerivative · entry 1

MOTT DAVID M · CIK 0001219871 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000860 · primary_01.xml · derivative · entry 4

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,420

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

SEC source: 0001593968-24-000860 · primary_01.xml · derivative · entry 3

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Common Stock · 15,630 shares

Expires 2034-06-12

SEC source: 0001593968-24-000860 · primary_01.xml · derivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,670 shares

Expires 2033-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000860 · primary_01.xml · nonDerivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000858 · primary_01.xml · derivative · entry 4

YOUNG JAMES F · CIK 0001219864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,420

Underlying: Common Stock · 10,420 shares

Expires 2034-06-12

SEC source: 0001593968-24-000858 · primary_01.xml · derivative · entry 3

YOUNG JAMES F · CIK 0001219864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,630

Underlying: Common Stock · 15,630 shares

Expires 2034-06-12

SEC source: 0001593968-24-000858 · primary_01.xml · derivative · entry 2

YOUNG JAMES F · CIK 0001219864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,670 shares

Expires 2033-06-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001593968-24-000858 · primary_01.xml · nonDerivative · entry 1

YOUNG JAMES F · CIK 0001219864 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-062148 · tm2414680-1_4seq1.xml · derivative · entry 3

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,728

Underlying: Common Stock · 19,652 shares

Expires 2033-03-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the March 7, 2023 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date.

SEC source: 0001104659-24-062148 · tm2414680-1_4seq1.xml · nonDerivative · entry 2

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,953

F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.86 to $14.00, inclusive. The Reporting Person undertakes to provide to Novavax, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001104659-24-062148 · tm2414680-1_4seq1.xml · nonDerivative · entry 1

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-25-009786 · tm255659-2_4seq1.xml · nonDerivative · entry 1

Alton Gregg H · CIK 0001334682 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,220

SEC source: 0001104659-25-009785 · tm255659-1_4seq1.xml · nonDerivative · entry 1

MCGLYNN MARGARET G · CIK 0001215126 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,829

SEC source: 0001104659-24-033621 · tm248710-3_4seq1.xml · derivative · entry 3

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,608

Underlying: Common Stock · 4,608 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-033621 · tm248710-3_4seq1.xml · nonDerivative · entry 2

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,285

SEC source: 0001104659-24-033621 · tm248710-3_4seq1.xml · nonDerivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-033620 · tm248710-2_4seq1.xml · derivative · entry 3

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,376

Underlying: Common Stock · 5,376 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date

F2 · derivative.expiration_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date

SEC source: 0001104659-24-033620 · tm248710-2_4seq1.xml · nonDerivative · entry 2

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,613

SEC source: 0001104659-24-033620 · tm248710-2_4seq1.xml · nonDerivative · entry 1

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,210

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-033619 · tm248710-1_4seq1.xml · derivative · entry 3

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,608

Underlying: Common Stock · 4,608 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 10, 2022, the Grant Date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 10, 2022, the Grant Date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-033619 · tm248710-1_4seq1.xml · nonDerivative · entry 2

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,972

SEC source: 0001104659-24-033619 · tm248710-1_4seq1.xml · nonDerivative · entry 1

Trizzino John · CIK 0001468534 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,198

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-033165 · tm248549-3_4seq1.xml · derivative · entry 3

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 38,886 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date

F2 · derivative.expiration_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date

SEC source: 0001104659-24-033165 · tm248549-3_4seq1.xml · nonDerivative · entry 2

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,834

SEC source: 0001104659-24-033165 · tm248549-3_4seq1.xml · nonDerivative · entry 1

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,226

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-033164 · tm248549-2_4seq1.xml · derivative · entry 3

Trizzino John · CIK 0001468534 · EVP, CCO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 57,780 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Amended and Restated 2015 Stock Incentive Plan will vest on each of the first three (3) anniversaries of March 7, 2023, the Grant Date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-033164 · tm248549-2_4seq1.xml · nonDerivative · entry 2

Trizzino John · CIK 0001468534 · EVP, CCO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,590

SEC source: 0001104659-24-033164 · tm248549-2_4seq1.xml · nonDerivative · entry 1

Trizzino John · CIK 0001468534 · EVP, CCO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,545

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-033163 · tm248549-1_4seq1.xml · derivative · entry 4

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,446

Underlying: Common Stock · 12,224 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F3 · derivative.exercise_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date.

F3 · derivative.expiration_date: The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-033163 · tm248549-1_4seq1.xml · nonDerivative · entry 2

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,903

SEC source: 0001104659-24-033163 · tm248549-1_4seq1.xml · nonDerivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · derivative · entry 3

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,200

Underlying: Common Stock · 19,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F2 · derivative.exercise_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · nonDerivative · entry 2

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,225

SEC source: 0001104659-24-031167 · tm248061-1_4seq1.xml · nonDerivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-24-039169 · tm249879-6_4seq1.xml · derivative · entry 1

Trizzino John · CIK 0001468534 · EVP, CCO and CBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,000

Underlying: Common Stock · 144,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-039166 · tm249879-5_4seq1.xml · derivative · entry 1

O'Hara Elaine · CIK 0001968045 · EVP, Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Common Stock · 120,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-039164 · tm249879-4_4seq1.xml · derivative · entry 1

Kelly James Patrick · CIK 0001506314 · EVP, CFO & Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,000

Underlying: Common Stock · 176,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

SEC source: 0001104659-24-039163 · tm249879-2_4seq1.xml · derivative · entry 1

Dubovsky Filip · CIK 0001977361 · President, R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,000

Underlying: Common Stock · 144,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F2 · derivative.exercise_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.

F2 · derivative.expiration_date: One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.